Moderna Inc. (MRNA)
NASDAQ
Closed
Oct 8, 2026
Day's Range
192.7152 wk Range
22.28Overview - MRNA - Moderna Inc.
Key Statistics
Valuation
Enterprise Value
72.00B
P/E (Trailing)
‪24.96‬
P/E (Forward)
‪-42.69‬
PEG Ratio
‪-3.32‬
Price / Sales (TTM)
‪34.04‬
Price / Book
‪11.21‬
EV / EBITDA
‪-32.80‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪-141.42%‬
Operating Margin
‪-557.93%‬
Return on Assets
‪-13.25%‬
Return on Equity
‪-38.99%‬
Ownership
Shares Outstanding
399.00M
Float
372.18M
Short % of Shares Outstanding
‪10.06%‬
Held by Insiders
‪7.33%‬
Held by Institutions
‪80.45%‬
Price stats
Beta
‪1.10‬
50-Day Avg
‪120.97‬
200-Day Avg
‪67.59‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
23 analysts
Average price target
‪$ 91.39‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRNA - Moderna Inc.
Peers - MRNA - Moderna Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- MRNANASDAQModerna Inc.75.85BMarket Cap+85.51%52-week change24.97P/E (Trailing)‪-141.42%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - MRNA - Moderna Inc.
About
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, rare diseases, autoimmune conditions, and other therapeutic areas.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
